A new study uses large-scale genetic approach to uncover human genes controlling HIV infection.
With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.
New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.
Five new members join the Gladstone Foundation Board
NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer's disease.
Gladstone researchers Warner C. Greene and Eytan Herzig collaborated with Xyphos Biosciences, Inc., to develop a novel immunotherapy for HIV.
The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego
Keller's work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine
Benoit Bruneau is selected to lead the Gladstone Institute of Cardiovascular Disease
The National Institutes of Health renews its funding of a promising internship program at the Gladstone Institutes
Basic science discovery explains a fundamental way human cells differ from yeast cells.
Study by Gladstone scientists finds blood protein destroys memory storage sites in the brain and may lead to new treatments
An unexpected brain region is important for Dravet Syndrome, finds study from the Gladstone Institutes
Insight into how three of the world's most devastating viruses interact with human cells opens the door for much-needed treatments
Shipman will build new technologies to understand the development of the brain
Gladstone scientists uncover new gatekeeper function of the anti-aging molecule
Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks
The NIH funds an initiative at the Gladstone Institutes to assess the safety of CRISPR-like therapies in human tissues
New discoveries about how cells self-organize could help researchers create more authentic organ models for research or transplantation
Robert Wicks appointed the new vice president of philanthropy
Gladstone researchers discover a noisy step in gene expression
Connecting the dots between human papillomavirus and smoking-related cancers
The co-inventor of CRISPR genome editing technology expands research collaborations to San Francisco's Mission Bay research community
New study from the Gladstone Institutes uncovers how the viruses bypass your body's defense mechanisms
Scientists shed light on cells' most fundamental process
Wernig was selected for his groundbreaking research in cellular reprogramming and stem cell-based therapies for genetic disease
Scientists from the Gladstone Institutes discover how to enhance the longevity of cells that kill tumors and infected cells
A team of scientists from the Gladstone Institutes, UCSF, and UC Berkeley identify nearly 200 potential drug targets
BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders
A new computational approach from the Gladstone Institutes identifies genes that may help microbes live successfully in the human gut
Scientists at Gladstone reveal how the virus decides between fates.
Gladstone and Google AI collaborate to uncover the tip of an iceberg that could transform biomedical science
Researchers at the Gladstone Institutes provide answers to decade-old questions
New insights into how a gene causes damage could impact future drug development
Transplanting a special type of neuron into the brain restores cognitive functions in Alzheimer's models, shows a new study by Gladstone scientists
Gladstone scientists identify genes that enable adult cells to divide and multiply
Gladstone launches the new Institute of Data Science and Biotechnology
Different routes of sexual transmission affect the immune system's response to a virus, shows new study.
Gladstone scientists show how a type of neuron improves procedural learning.
Scientists examine the fastest changing regions in the human genome to learn how our species evolved.
Activating a single gene is sufficient to change skin cells into stem cells.
Study will use innovative technology to focus on neurodegenerative diseases
New study explains what happens when the immune system ages
Study from the Gladstone Institutes may lead to new treatments for diseases like multiple sclerosis
Scientists develop a cheaper, quicker, and more reliable stem cell-based technology to facilitate drug discovery
The term begins on January 1, 2018
An unexpected collaboration leads to the discovery of an early predictor of IBD
A single drug could attack the virus on two fronts
The discovery could improve treatments for autoimmune diseases and cancer
Simon takes on a central role in shaping Gladstone's future
Studer was selected for his groundbreaking research in stem cell-based therapies for Parkinson's disease
E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders
Researchers show that semen amyloids help the human body dispose of excess and defective sperm
Gladstone investigator is elected VP of the preeminent organization dedicated to stem cell research and treatments
Cells related to seizures, schizophrenia and ADHD all found in the same region of the brain
Discovery at Gladstone Institutes will help reevaluate the cause of certain cancers and developmental defects
Gladstone scientists uncovered a possible strategy to "shock and kill" the virus that hides in cells
Gladstone scientists are the first to produce a type of stem cell-derived neuron that could potentially help restore movement
Gladstone scientists identify inflammatory pathways as a potential therapeutic target for frontotemporal dementia
